HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Søren Andersen Selected Research

Innovin

8/2010Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Søren Andersen Research Topics

Disease

2Hemophilia A (Haemophilia)
01/2021 - 08/2010
2Type 2 Diabetes Mellitus (MODY)
03/2012 - 04/2010
2Neoplasms (Cancer)
03/2012 - 04/2010
2Hyperplasia
03/2012 - 04/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2011
1Ischemia
06/2006
1Heart Arrest (Cardiac Arrest)
06/2006
1Ventricular Tachycardia
06/2006

Drug/Important Bio-Agent (IBA)

2Thromboplastin (Tissue Factor)IBA
01/2021 - 08/2010
2LiraglutideFDA Link
03/2012 - 04/2010
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2012 - 04/2010
1concizumabIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Exenatide (Byetta)FDA Link
03/2012
1Glucagon-Like Peptide ReceptorsIBA
03/2012
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2011
1InnovinIBA
08/2010
1recombinant FVIIa (rFVIIa)FDA Link
08/2010
1KaolinIBA
08/2010
1Tissue Plasminogen Activator (Alteplase)FDA Link
08/2010
1Glucagon-Like Peptide 1 (GLP 1)IBA
04/2010
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
04/2010
1rotigaptideIBA
06/2006
1Connexin 43 (Connexin43)IBA
06/2006
1antiarrhythmic peptide (AAP)IBA
06/2006

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
05/2011
1Therapeutics
08/2010